Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Liu-Cheng Li, Yong-Yue Han, Zhi-Hui Zhang, Wen-Cheng Zhou, Hong-Mei Fang, Jiao Qu & Lian-Di Kan. (2021) Chronic Obstructive Pulmonary Disease Treatment and Pharmacist-Led Medication Management. Drug Design, Development and Therapy 15, pages 111-124.
Read now
Read now
Carlos Cabrera López, Enrique Mascarós, Angel Azpeitia & Elena Villarrubia. (2020) A Simplified Algorithm for the Diagnosis, Treatment, and Management of COPD in Routine Primary Care Practice. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 3347-3355.
Read now
Read now
Dat T Tran, Ilke Akpinar, Irvin Mayers, Tatiana Makhinova & Philip Jacobs. (2019) Temporal Trends Of Pharmacologic Therapies For Patients With Chronic Obstructive Pulmonary Disease In Alberta, Canada. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2245-2256.
Read now
Read now
Chad Moretz, Lucie Sharpsten, Lindsay GS Bengtson, Eleena Koep, Lisa Le, Junliang Tong, Richard H Stanford, Beth Hahn & Riju Ray. (2019) Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1721-1737.
Read now
Read now
Maria Gabriella Matera, Luigino Calzetta, Ermanno Puxeddu, Paola Rogliani & Mario Cazzola. (2018) A safety comparison of LABA+LAMA vs LABA+ICS combination therapy for COPD. Expert Opinion on Drug Safety 17:5, pages 509-517.
Read now
Read now
Zaurbek Aisanov, Sergey Avdeev, Vladimir Arkhipov, Andrey Belevskiy, Alexander Chuchalin, Igor Leshchenko, Svetlana Ovcharenko, Evgeny Shmelev & Marc Miravitlles. (2018) Russian guidelines for the management of COPD: algorithm of pharmacologic treatment. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 183-187.
Read now
Read now
Articles from other publishers (11)
Eimir Hurley, Sarah-Jo Sinnott, Tim McDonnell, Tim Delaney, Maire O’Connor & Charles Normand. (2020) Deciphering patterns of respiratory medication use in Ireland to target interventions appropriately: a focus on COPD. Irish Journal of Medical Science (1971 -) 190:3, pages 1103-1109.
Crossref
Crossref
Jennifer K. Quint, Jukka Montonen, Daina B. Esposito, Xintong He, Leslie Koerner, Laura Wallace, Alberto de la Hoz & Marc Miravitlles. (2021) Effectiveness and Safety of COPD Maintenance Therapy with Tiotropium/Olodaterol versus LABA/ICS in a US Claims Database. Advances in Therapy 38:5, pages 2249-2270.
Crossref
Crossref
Randy Sorge & Peter DeBlieux. (2020) Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Primer for Emergency Physicians. The Journal of Emergency Medicine 59:5, pages 643-659.
Crossref
Crossref
Tanja Fens, Simon van der Pol, Janwillem W.H. Kocks, Maarten J. Postma & Job F.M. van Boven. (2019) Economic Impact of Reducing Inappropriate Inhaled Corticosteroids Use in Patients With Chronic Obstructive Pulmonary Disease: ISPOR's Guidance on Budget Impact in Practice. Value in Health 22:10, pages 1092-1101.
Crossref
Crossref
Nicolas Roche, Bernard Aguilaniu, Pei Zhi Li & David Hess. (2019) Trends over time in COPD treatment choices by respiratory physicians: An analysis from the COLIBRI-COPD French cohort. Respiratory Medicine 156, pages 8-14.
Crossref
Crossref
Toshio Nakaki. 2019. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions
151
161
.
James D. Chalmers, Chris Poole, Samantha Webster, Abigail Tebboth, Scott Dickinson & Alicia Gayle. (2018) Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Respiratory Research 19:1.
Crossref
Crossref
Han-Rong Feng, Chao Zhang & Song-Min Ying. (2018) Classical and Emerging Therapies against Chronic Obstructive Pulmonary Disease. Chinese Medical Journal 131:16, pages 1894-1897.
Crossref
Crossref
Wenhui Cui, Zhihui Zhang, Panpan Zhang, Jiao Qu, Cheng Zheng, Xiaoting Mo, Wencheng Zhou, Liang Xu, Hongwei Yao & Jian Gao. (2018)
Nrf2 attenuates inflammatory response in
COPD
/emphysema: Crosstalk with Wnt3a/β‐catenin and
AMPK
pathways
. Journal of Cellular and Molecular Medicine 22:7, pages 3514-3525.
Crossref
Crossref
Adrian Gillissen. (2018) Tripletherapie bei COPD effektiver als LABA-LAMA-Kombination. Pneumo News 10:2, pages 24-26.
Crossref
Crossref
Marc Miravitlles, Borja G. Cosío, Aurelio Arnedillo, Myriam Calle, Bernardino Alcázar-Navarrete, Cruz González, Cristóbal Esteban, Juan Antonio Trigueros, José Miguel Rodríguez González-Moro, José Antonio Quintano Jiménez & Adolfo Baloira. (2017) A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease. Respiratory Research 18:1.
Crossref
Crossref